Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 1

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 3
Chunk 1
---

participates is competitive, and if NewGenIvf does not continue to compete effectively, its results of operations could be materially
and adversely affected.

The market for NewGenIvf’s
solutions is competitive and is likely to attract increased competition, which could make it hard for it to succeed. NewGenIvf faces significant
competition from other fertility companies and other players in the fertility market. Some of NewGenIvf’s competitors are more established,
have a longer operating history and a larger client base, benefit from greater brand recognition and have substantially greater financial,
technical and marketing resources than NewGenIvf does. NewGenIvf’s competitors may compete with NewGenIvf in a variety of ways,
including seeking to develop or integrating solutions and services that may become more efficient or appealing to NewGenIvf’s existing
and potential clients, achieving superior clinical outcomes, having access to a network of more high-quality fertility specialists, establishing
more comprehensive data reporting and sharing systems, conducting brand promotions and other marketing activities, and making investments
in and acquisitions of NewGenIvf’s business partners. While NewGenIvf believes that one of its key competitive advantages is its
ability to provide a broad range of services, and NewGenIvf does not believe any competitors have developed a similar broad range services
in Asia Pacific at this time, current or future competitors may be successful in doing so in the future. If current or future competitors
are successful at developing a similar broad range of services, NewGenIvf’s financial performance may be negatively impacted.

In addition, NewGenIvf believes
that there is growing awareness of the demand for fertility services. As the fertility services field gains more attention, more competitors
may be drawn into the market. NewGenIvf also could be adversely affected if NewGenIvf fails to identify or effectively respond to changes
in market dynamics. As a result of any of these factors, NewGenIvf may not be able to continue to compete successfully against its current
or future competitors, and this competition could result in the decrease in its client base and market share and the failure of its platform
to continue to maintain market acceptance, which would materially and adversely affect its business, financial condition and results of
operations.

NewGenIvf has a limited operating history
with its current platform of solutions, which makes it difficult to predict its future prospects, financial performance and results of
operations.

The predecessor entity of
the Company prior to the Business Combination in April of